PG — FY2026 Annual Report Analysis

Currency and price carried the year; the underlying business did not

Procter & Gamble closed fiscal 2026 (the twelve months ended June 30, 2026) with net sales up 3% to $87.0 billion — but essentially none of that came from selling more product. The 10-K breaks the increase into 2 percentage points of favorable foreign exchange (the dollar value of sales made in other currencies, translated back into dollars) and 1 point of higher pricing, with unit volume and mix unchanged. Organic sales — P&G's measure of sales growth stripped of currency swings and of businesses bought or sold, so it shows the underlying demand trend — grew 1%, down from 2% in fiscal 2025.

Profit moved the other way. Operating income fell 3% to $19.7 billion and operating margin — the share of each sales dollar left after the costs of making and selling the product, before interest and tax — dropped 160 basis points (1.6 percentage points) to 22.7%. Reported net earnings attributable to P&G were essentially flat at $16.0 billion, and that flat line was held up by items below the operating line rather than by the business itself.

Key figures

Core EPS is P&G's own adjusted figure, excluding the gain on unwinding the Glad joint venture and restructuring charges above its normal run-rate. On a currency-neutral basis — removing the exchange-rate help — core EPS was unchanged versus the prior year, per the July 29, 2026 earnings release.

What actually moved the margin

Gross margin — the share of sales left after the direct cost of making the goods — fell 100 basis points to 50.2%. The 10-K itemizes it, and the composition matters more than the headline:

Two things stand out. First, productivity savings of 180 basis points were large and still not enough — the offsetting pressures totaled 320 basis points. Second, the single biggest drag was product mix, meaning growth came disproportionately from lower-margin products and lower-margin geographies rather than from any single cost shock. Tariffs cost 30 basis points net of recoveries, which is real but is not the main story.

Below gross margin, SG&A (selling, general and administrative expense) rose 6% to $23.9 billion and climbed 60 basis points to 27.5% of sales, driven by an 80-basis-point increase in marketing spending. Overhead as a share of sales was flat, with wage inflation and restructuring spending offset by productivity savings worth 160 basis points. So P&G spent more on advertising into a market where volume did not grow.

Why net earnings held flat when operating profit fell

Operating income dropped $703 million, yet earnings before income taxes rose $210 million to $20.4 billion. The bridge is entirely non-operating: other non-operating income rose $922 million to $1.1 billion, for two reasons the 10-K names — the prior year carried a non-cash charge for accumulated currency translation losses from substantially liquidating P&G's Argentina operations, and the current year included the dissolution of the Glad joint venture. Clorox bought out P&G's minority stake for $476 million in January 2026, producing a $261 million after-tax gain.

The effective tax rate — tax as a share of pre-tax profit — rose to 20.8% from 20.3%, on lower stock-compensation tax benefits and unfavorable geographic mix, trimming some of that benefit. Net earnings attributable to P&G ended $72 million higher at $16.0 billion.

Diluted EPS rose 2% to $6.62, and the 10-K attributes that to both higher earnings and a reduced share count — P&G repurchased $5.0 billion of stock during the year. Currency also helped the bottom line directly: foreign exchange increased net earnings by roughly $224 million.

Takeaway: Every line of fiscal 2026 growth is borrowed from somewhere other than the core business — 2 points of sales growth from currency, 1 from price, zero from volume; flat net earnings held up by a joint-venture gain and an easy prior-year comparison; EPS growth partly bought with buybacks. Strip those out and currency-neutral core EPS was exactly flat, with all five segments posting lower earnings margins.

Segments: Beauty grew, and still earned less

All five segments grew sales and all five earned less money than a year earlier. Beauty was the only segment with meaningful volume growth (units up 4%), led by hair care volume gains in Latin America, Europe and Asia Pacific and by personal care growth across every region — yet its net earnings fell 2% as mix and higher commodity costs took 100 basis points off its gross margin and marketing spending rose. Skin care volume fell, with the decline concentrated in Greater China on competitive activity; sales there were carried by the super-premium SK-II brand, which sells above the category average price — a textbook mix effect, where reported sales hold up because the products sold were pricier, not because more were sold.

Fabric & Home Care, the largest segment at $30.3 billion, grew 2% on currency and price with flat volume, and its earnings fell 4% — the steepest decline of the five — on a 140-basis-point gross margin drop from mix and commodities. Baby, Feminine & Family Care was the only segment with negative organic sales; Family Care, a predominantly North American business, saw both lower pricing from merchandising investments and lower volume from competitive activity, and North American family care market share fell 0.7 points.

Market share is the quiet warning: P&G lost share in Beauty (−0.3 points), Grooming (−0.4) and Baby, Feminine & Family Care (−0.2), was flat in Fabric & Home Care, and gained only in Health Care (+0.4). That is share slipping while marketing spending rises.

The exit rate was worse than the year

The June quarter — fiscal Q4 — was materially weaker than the full year. Net sales rose 2% to $21.2 billion, with foreign exchange and rounding contributing 1 point each and volume, price and mix all neutral; organic sales were flat. Diluted EPS fell 15% to $1.26 and core EPS fell 3% to $1.43, with currency-neutral core EPS down 5%. By segment, Q4 organic sales were +4% in Beauty, flat in Grooming and Fabric & Home Care, −1% in Health Care and −2% in Baby, Feminine & Family Care. Fiscal 2026 did not end on its own average — it ended below it, which is the relevant starting point for fiscal 2027 guidance.

Cash, capital return and the restructuring

Operating cash flow rose 10% to $19.6 billion. Adjusted free cash flow — operating cash flow less capital spending, excluding the final payment of the transition tax from the 2017 U.S. tax law — was $15.8 billion, and adjusted free cash flow productivity (that cash as a percentage of net earnings) was 100%, up from 87%. In plain terms, P&G converted essentially all of its accounting profit into spendable cash, which is a genuinely good result in a year when the profit itself stalled.

P&G returned over $15 billion: $10.2 billion in dividends and $5.0 billion in buybacks. The April 2026 increase marked the 70th consecutive year of dividend increases and the 136th consecutive year of paying one.

The June 2025 two-year portfolio and productivity plan is the structural piece. P&G booked $903 million of incremental after-tax restructuring charges under it in fiscal 2026 — over half the program's total cost — with the remainder expected in fiscal 2027. The plan includes cutting up to 7,000 non-manufacturing overhead roles by the end of fiscal 2027, plus brand and market exits and supply-chain optimization. (Note the two cost figures floating around: the 10-K cites roughly $1.5–2.0 billion before tax including the company's ongoing baseline restructuring, while the earnings release cites $1–1.6 billion of non-core charges, which excludes that baseline. They describe the same program.)

On August 4, 2026 — the day the 10-K was filed — P&G agreed to buy Thorne, a premium vitamins, minerals and supplements brand, for $3.8 billion, with closing expected in the second quarter of fiscal 2027 subject to regulatory approval. It is the clearest signal yet of where new CEO Shailesh Jejurikar intends to add growth that the existing portfolio is not producing.

Fiscal 2027 guidance and what it implies

Management guided to:

The cost side of that guidance is unusually explicit: roughly $1 billion after tax from higher raw materials, energy and transportation costs, $150 million from higher net interest expense, $150 million from lower non-operating income, and $50 million from unfavorable currency — together $0.56 per share, which management describes as an 8-percentage-point drag on core EPS growth. To land at the midpoint of flat-to-plus-3% core EPS, P&G has to generate close to 9 points of offsetting productivity and pricing.

Our read: the guidance is coherent but leaves no slack. The organic sales range of 1–3% requires acceleration from the 0% P&G just printed in the June quarter, and management is explicitly counting on improvement "from semester-to-semester" rather than immediately. The $1 billion commodity headwind is the same category of pressure that already cost 20 basis points of gross margin in fiscal 2026, only larger. Against that, the levers are real: productivity savings delivered 180 basis points of gross margin and 160 basis points of SG&A benefit this year, the restructuring removes up to 7,000 overhead positions by the end of fiscal 2027, and cash conversion at 100% comfortably funds the $15 billion of planned dividends and buybacks without new debt.

The thing to watch is not the EPS line, which buybacks and productivity can largely engineer, but volume and market share. Fiscal 2026 delivered zero unit growth and share losses in three of five segments while marketing spending rose — that combination is what determines whether the 1–3% organic range is met from real demand or from another year of price and currency. The Thorne acquisition, and whatever else follows it, is the acknowledgment that the existing portfolio is not currently supplying that growth on its own.